Further analysis of publicly available datasets40,43,44 revealed higher expression of RICTOR in patients with (BCR-ABL+) B-ALL compared to healthy controls and AML, including AML patients with MLL rearrangements (Fig. 8E; Supplementary Fig. 21G). This evidence concerns the gene KMT2A and acute myeloid leukemia.